A pharmaceutical manufacturing firm has previously spent $2.2 million of cash outlays on R&D. The CFO says that they have no effect on the cash flows relevant to the current investment decision; they are called

Group of answer choices

1.) opportunity costs foregone.

2.) incremental historical costs.

3.) incremental past expenses.

4.) sunk costs.